Involvement of IFNβ on IFNγ and nitric oxide (NO) production by bone marrow (BM) cells in response to lipopolysaccharide

Biomedicine and Pharmacotherapy

Volumn 60, Issue 9, 2006, Pages 541-547

  Campillo, J A ^a,b   Pelaez B ^a   Angulo, I ^a   Bensussan, A ^b   Subiza, J L ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Bone marrow cells; Nitric oxide; Proinflammatory cytokines

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL LINEAGE; FEMALE; METABOLISM; MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; BONE MARROW CELLS; CELL LINEAGE; FEMALE; INTERFERON TYPE II; INTERFERON-BETA; INTERLEUKIN-12; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; T-LYMPHOCYTES;

EID: 33750310879     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.07.085     Document Type: Article

References (35)

1. Sugiura K., Ikehara S., Inaba M., Haraguchi S., Ogata H., Sardiña E.E., et al. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. Exp. Hematol. 20 (1992) 256-263
2. Strober S. Natural suppressor cells (NS) cells, neonatal tolerance and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2 (1984) 219-237
3. Holda J.H., Maier T., and Claman H.N. Murine graft-versus-host disease across minor barriers: immunosuppresive aspects of natural suppressor cells. Immunol. Rev. 88 (1985) 87-105
4. Brooks-Kaiser J.C., Bourque L.A., and Hoskin D.W. Heterogeny of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide. Immunopharmacology 25 (1993) 117-129
5. Subiza J.L., Viñuela J.E., Rodríguez R., Gil J., Figueredo M.A., and de la Concha E.G. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int. J. Cancer 44 (1989) 307-314
6. Rodríguez R., Angulo I., Viñuela J.E., Medina M., Gil J., and Subiza J.L. Inhibition of bone marrow-derived natural suppressor activity by glucocorticoids and its reversal by IFN-γ and IL-2. Transplantation 58 (1994) 511-517
7. Angulo I., Rodríguez R., García B., Medina M., Navarro J., and Subiza J.L. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-γ. J. Immunol. 155 (1995) 15-26
8. Sugiura K., Pahwa S., Yamamoto Y., Borisov K., Pahwa R., Nelson Jr. R.P., et al. Characterization of natural suppressor cells in human bone marrow. Stem Cells 16 (1998) 99-106
9. Angulo I., Rullas J., Campillo J.A., Obregón E., Heath A., Howard M., et al. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-γ stimulation through a mechanism dependent on endogenous TNF-α and IL-1α. Eur. J. Immunol. 30 (2000) 1263-1271
10. Punjabi C.J., Laskin D.L., Heck D.E., and Laskin J.D. Production of nitric oxide by murine bone marrow cells. Inverse correlation with cellular proliferation. J. Immunol. 149 (1992) 2179-2184
11. Angulo I., de las Heras F.G., García-Bustos J.F., Gargallo D., Muñoz-Fernández M.A., and Fresno M. Nitric oxide-producing CD11b+Ly6G (Gr-1)+ CD31 (ER-MP12)+ cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 95 (2000) 212-220
12. Peláez B., Campillo J.A., López-Asenjo J.A., and Subiza J.L. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166 (2001) 6608-6615
13. Bobe P., Benihoud K., Grandjon D., Opolon P., Pritchard L., and Huchet R. Nitric oxide mediation of active immunosuppression associated with grat-versus-host reaction. Blood 94 (1999) 1028-1037
14. Billiau A.D., Fevery S., Rutgeerts O., Landuyt W., and Waer M. Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions. Blood 102 (2003) 740-748
15. Kusmartsev S.A., Li Y., and Chen S.H. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 co-stimulation. J. Immunol. 165 (2000) 779-785
16. Stuehr D.J., and Griffith O.W. Mammalian nitric oxide synthases. Adv. Immunol. 65 (1992) 287-326
17. Tominaga K., Yoshimoto T., Torigoe K., Kurimoto M., Matsui K., Hada T., et al. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int. Immunol. 12 (2000) 151-160
18. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161 (1998) 3400-3407
19. Ahn H.-J., Mauro S., Tomura M., Mu J., Hamaoka T., Nakanishi K., et al. A mechanism underlying synergy between IL-12 and IFNγ-inducing factor in enhanced production of IFN-γ. J. Immunol. 159 (1997) 2125-2131
20. Yaegashi Y., Nielsen P., Sing A., Galanos C., and Freudenberg M.A. Interferon β, a cofactor in the interferon γ production induced by gram-negative bacteria in mice. J. Exp. Med. 181 (1995) 953-960
21. 15N] nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
22. Fujihara M., Ito N., Pace J.L., Watanabe Y., Russell S.W., and Suzuki T. Role of endogenous interferon-β in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J. Biol. Chem. 269 (1994) 12773-12778
23. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., and Murphy W.J. Autocrine/paracrine IFN-α/β mediates the lipopolysaccharide-induced activation of transcription factor stat-1α in mouse macrophages: pivotal role of stat-1α in induction of the inducible nitric oxide synthase gene. J. Immunol. 161 (1998) 4803-4810
24. Saito S., Matsuura M., Tominaga K., Kirikae T., and Nakano M. Important role of membrane-associated CD14 in the induction of IFN-beta and subsequent nitric oxide production by murine macrophages in response to bacterial lipopolysaccharide. Eur. J. Biochem. 267 (2000) 37-45
25. Jacobs A.T., and Ignarro L.J. Cell density-enhanced expression of inducible nitric oxide synthase in murine macrophages mediated by interferon-beta. Nitric Oxide 8 (2003) 222-230
26. Sugiyama T., Fujita M., Koide N., Mori I., Yoshida T., Mori H., et al. 2-Aminopurine inhibits lipopolysaccharide-induced nitric oxide production by preventing IFN-beta production. Microbiol. Immunol. 48 (2004) 957-963
27. Cleveland M.G., Lane R.G., and Klimpel G.R. Spontaneous IFN-β production. A common feature of natural suppressor systems. J. Immunol. 141 (1988) 2043-2049
28. Shmidt-Wolf I.G.H., Dejbakhsh-Jones S., Ginzton N., Greenberg P., and Strober S. T-cell subset and suppressor cells in human bone marrow. Blood 80 (1992) 3242-3250
29. Strober S. Natural Killer 1.1 (+) T cells and "natural suppressor" T cells in the bone marrow. J. Allergy Clin. Immunol. 106 (2000) S113-S114
30. Mysliwietz J., Thierfelder S., Hoffmann-Fezer G., and Kummer U. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies. Transplantation 49 (1990) 749-755
31. Marrack P., Kappler J., and Mitchell T. Type I interferons keep activated T cells alive. J. Exp. Med. 189 (1999) 521-530
32. Pilling D., Akbar A.N., Girdlestone J., Orteu C.H., Borthwick N.J., Amft N., et al. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29 (1999) 1041-1050
33. Sadelain M.W., Gren D.R., and Wegmann T.G. Host natural suppressor activity regulates hemopoietic engraftment kinetics in antibody-conditioned recipient mice. J. Immunol. 144 (1990) 1729-1736
34. Price K.S., Nestel F.P., and Lapp W.S. Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease. Scand. J. Immunol. 45 (1997) 294-300
35. Falzarano G., Krenger W., Synder K.M., Delmonte J., Karandikar M., and Ferrara J.L.M. Suppression of B cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-α in mice with acute graft-versus-host disease. Blood 87 (1996) 2853-2860